Cig Shanghai (06166) announced its mid-term performance, with a net profit attributable to the parent company of approximately 328 million yuan, a year-on-year increase of 171.08%.
Cambridge Technology (06166) announced its interim results for 2026, with operating revenue of approximately 2.705 billion yuan, a year-on-year increase of 32.92%; net profit attributable to shareholders of the listed company of approximately 328 million yuan, a year-on-year increase of 171.08%; net profit after deducting non-recurring gains and losses of 319 million yuan, a year-on-year increase of 168.42%; basic earnings per share of 0.93 yuan.
Cig Shanghai (06166) announced its interim results for 2026, with operating revenue of approximately 2.705 billion yuan, a year-on-year increase of 32.92%; net profit attributable to shareholders of the listed company was approximately 328 million yuan, a year-on-year increase of 171.08%; net profit after deducting non-recurring gains and losses was 319 million yuan, a year-on-year increase of 168.42%; basic earnings per share were 0.93 yuan.
During the reporting period, the companys performance was driven by the high-quality development of its three core businesses: high-speed optical modules, broadband access, and wireless access. Among these, the high-speed optical module business performed particularly well. On one hand, strong market demand led to a significant increase in orders, and the company supported a substantial year-on-year growth in shipment value by ensuring high-quality and timely deliveries; on the other hand, the optimization of the product structure significantly boosted the sales gross margin.
Related Articles

PENGO HLDG GP (01865) issued 147 million shares according to the subscription agreement.

ABBISKO-B(02256): It is recommended that the Chinese double foreign name be changed to "Heyu Pharmaceutical Limited Liability Company."

HUAYUEXPRESSWAY (01823) issues profit warning, expecting a mid-term shareholder loss of approximately 34.5 million to 38.1 million yuan.
PENGO HLDG GP (01865) issued 147 million shares according to the subscription agreement.

ABBISKO-B(02256): It is recommended that the Chinese double foreign name be changed to "Heyu Pharmaceutical Limited Liability Company."

HUAYUEXPRESSWAY (01823) issues profit warning, expecting a mid-term shareholder loss of approximately 34.5 million to 38.1 million yuan.

RECOMMEND





